Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.0 EUR
61.85 M EUR
1.02 B EUR
44.46 M
About Kobayashi Pharmaceutical Co., Ltd.
Sector
Industry
CEO
Norikaz Toyoda
Website
Headquarters
Osaka
Founded
1886
ISIN
JP3301100008
FIGI
BBG000CBWSV0
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic Business and International Business. The Domestic Business segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International Business segment sells beauty and health care products overseas. . The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KOY is 28.6 EUR — it has decreased by −0.69% in the past 24 hours. Watch Kobayashi Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Kobayashi Pharmaceutical Co., Ltd. stocks are traded under the ticker KOY.
KOY stock has fallen by −5.30% compared to the previous week, the month change is a −7.14% fall, over the last year Kobayashi Pharmaceutical Co., Ltd. has showed a −16.37% decrease.
We've gathered analysts' opinions on Kobayashi Pharmaceutical Co., Ltd. future price: according to them, KOY price has a max estimate of 38.29 EUR and a min estimate of 28.00 EUR. Watch KOY chart and read a more detailed Kobayashi Pharmaceutical Co., Ltd. stock forecast: see what analysts think of Kobayashi Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
KOY stock is 0.70% volatile and has beta coefficient of 0.59. Track Kobayashi Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Kobayashi Pharmaceutical Co., Ltd. there?
Today Kobayashi Pharmaceutical Co., Ltd. has the market capitalization of 2.20 B, it has decreased by −1.04% over the last week.
Yes, you can track Kobayashi Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Kobayashi Pharmaceutical Co., Ltd. is going to release the next earnings report on Nov 11, 2025. Keep track of upcoming events with our Earnings Calendar.
KOY earnings for the last quarter are 0.12 EUR per share, whereas the estimation was 0.14 EUR resulting in a −13.64% surprise. The estimated earnings for the next quarter are 0.25 EUR per share. See more details about Kobayashi Pharmaceutical Co., Ltd. earnings.
Kobayashi Pharmaceutical Co., Ltd. revenue for the last quarter amounts to 214.48 M EUR, despite the estimated figure of 226.29 M EUR. In the next quarter, revenue is expected to reach 250.28 M EUR.
KOY net income for the last quarter is 9.08 M EUR, while the quarter before that showed 10.01 M EUR of net income which accounts for −9.23% change. Track more Kobayashi Pharmaceutical Co., Ltd. financial stats to get the full picture.
Kobayashi Pharmaceutical Co., Ltd. dividend yield was 1.64% in 2024, and payout ratio reached 75.32%. The year before the numbers were 1.49% and 37.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 10, 2025, the company has 3.62 K employees. See our rating of the largest employees — is Kobayashi Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kobayashi Pharmaceutical Co., Ltd. EBITDA is 179.76 M EUR, and current EBITDA margin is 19.86%. See more stats in Kobayashi Pharmaceutical Co., Ltd. financial statements.
Like other stocks, KOY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kobayashi Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kobayashi Pharmaceutical Co., Ltd. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kobayashi Pharmaceutical Co., Ltd. stock shows the strong sell signal. See more of Kobayashi Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.